Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
97.19
+5.19 (5.64%)
At close: Sep 12, 2025, 4:00 PM EDT
97.38
+0.19 (0.20%)
Pre-market: Sep 15, 2025, 5:06 AM EDT
Nutex Health Revenue
Nutex Health had revenue of $211.79M in the quarter ending March 31, 2025, with 213.98% growth. This brings the company's revenue in the last twelve months to $624.28M, up 141.25% year-over-year. In the year 2024, Nutex Health had annual revenue of $479.95M with 93.80% growth.
Revenue (ttm)
$624.28M
Revenue Growth
+141.25%
P/S Ratio
0.82
Revenue / Employee
$780,356
Employees
800
Market Cap
539.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 479.95M | 232.30M | 93.80% |
Dec 31, 2023 | 247.65M | 28.35M | 12.93% |
Dec 31, 2022 | 219.29M | -112.24M | -33.85% |
Dec 31, 2021 | 331.53M | 57.50M | 20.98% |
Dec 31, 2020 | 274.03M | 176.97M | 182.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NUTX News
- 1 day ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nutex Health - PRNewsWire
- 3 days ago - Nutex Health Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 10 days ago - Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements-- Hagens Berman - PRNewsWire
- 12 days ago - Shareholders who lost money in shares of Nutex Health Inc. (NASDAQ: NUTX) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 20 days ago - Nutex Health Inc. (NUTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Lawsuit - PRNewsWire
- 20 days ago - Nutex Health (NUTX) Securities Suit Alleges Fraud and Financial Misstatements – Hagens Berman - GlobeNewsWire
- 20 days ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Nutex Health Inc. (NUTX) - GlobeNewsWire